Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiosurgery | 13 | 2024 | 1341 | 1.180 |
Why?
|
Prostatic Neoplasms | 13 | 2022 | 11075 | 0.570 |
Why?
|
Insurance Coverage | 1 | 2020 | 1919 | 0.320 |
Why?
|
Brachytherapy | 3 | 2021 | 1224 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5272 | 0.230 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2024 | 366 | 0.180 |
Why?
|
Prostate-Specific Antigen | 5 | 2021 | 2461 | 0.180 |
Why?
|
Sex | 1 | 2019 | 53 | 0.170 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13267 | 0.150 |
Why?
|
Penile Erection | 1 | 2018 | 100 | 0.150 |
Why?
|
Self-Help Devices | 1 | 2018 | 62 | 0.150 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2015 | 88 | 0.130 |
Why?
|
Testis | 1 | 2019 | 794 | 0.130 |
Why?
|
Radiotherapy Dosage | 5 | 2021 | 2895 | 0.130 |
Why?
|
Embolization, Therapeutic | 1 | 2024 | 1406 | 0.120 |
Why?
|
Paralysis | 1 | 2015 | 250 | 0.110 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 444 | 0.110 |
Why?
|
Anus Neoplasms | 1 | 2017 | 329 | 0.110 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2020 | 800 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20999 | 0.100 |
Why?
|
Plasmodium | 1 | 2015 | 247 | 0.100 |
Why?
|
Macrophages | 2 | 2024 | 5736 | 0.100 |
Why?
|
Ejaculation | 2 | 2022 | 59 | 0.100 |
Why?
|
Quality of Life | 4 | 2022 | 13265 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 933 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4888 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 977 | 0.080 |
Why?
|
Antimalarials | 1 | 2015 | 905 | 0.080 |
Why?
|
Testosterone | 1 | 2019 | 2466 | 0.080 |
Why?
|
Carboxylesterase | 1 | 2006 | 31 | 0.070 |
Why?
|
Melanoma | 1 | 2024 | 5690 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9245 | 0.060 |
Why?
|
Kinetics | 3 | 2020 | 6371 | 0.060 |
Why?
|
Male | 17 | 2024 | 358227 | 0.060 |
Why?
|
Prospective Studies | 7 | 2022 | 54108 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2006 | 745 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2024 | 79982 | 0.050 |
Why?
|
Aged | 12 | 2024 | 167889 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4021 | 0.050 |
Why?
|
Androgen Antagonists | 2 | 2021 | 1407 | 0.050 |
Why?
|
Humans | 22 | 2024 | 757650 | 0.050 |
Why?
|
Urogenital System | 1 | 2021 | 88 | 0.050 |
Why?
|
Cell Separation | 1 | 2006 | 1720 | 0.050 |
Why?
|
Lymphatic Irradiation | 1 | 2021 | 115 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12047 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6325 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2024 | 772 | 0.040 |
Why?
|
Medicare | 1 | 2017 | 6717 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2021 | 6808 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 628 | 0.040 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2004 | 803 | 0.040 |
Why?
|
Age Factors | 3 | 2019 | 18328 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 219219 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2015 | 51 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2020 | 471 | 0.030 |
Why?
|
Rectum | 1 | 2020 | 891 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 830 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 462 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21990 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12400 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2022 | 39018 | 0.030 |
Why?
|
Phagosomes | 1 | 2015 | 199 | 0.030 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2015 | 246 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15532 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58559 | 0.030 |
Why?
|
Pelvis | 1 | 2017 | 732 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11083 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 2015 | 461 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1627 | 0.030 |
Why?
|
Prostatectomy | 1 | 2020 | 1823 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39815 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3047 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3839 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18123 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1746 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8426 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2020 | 1659 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1264 | 0.020 |
Why?
|
Female | 5 | 2024 | 389985 | 0.020 |
Why?
|
Prostate | 1 | 2019 | 1761 | 0.020 |
Why?
|
Electromyography | 1 | 2015 | 1388 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1887 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 64242 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3595 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4057 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2004 | 10416 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6231 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2696 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16891 | 0.020 |
Why?
|
Autophagy | 1 | 2015 | 1322 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2743 | 0.020 |
Why?
|
Malaria | 1 | 2015 | 1226 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6293 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 41198 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8164 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10075 | 0.010 |
Why?
|
Homeostasis | 1 | 2015 | 3302 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2015 | 3102 | 0.010 |
Why?
|
Young Adult | 2 | 2024 | 58764 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11065 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10497 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81107 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12685 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5722 | 0.010 |
Why?
|
Mitochondria | 1 | 2015 | 3584 | 0.010 |
Why?
|
Molecular Structure | 1 | 2006 | 1865 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7926 | 0.010 |
Why?
|
Adult | 3 | 2024 | 219747 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15209 | 0.010 |
Why?
|
Animals | 2 | 2024 | 167777 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3095 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1664 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36271 | 0.010 |
Why?
|
Equipment Design | 1 | 2004 | 3501 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23819 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 87832 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13603 | 0.010 |
Why?
|
Cell Line | 1 | 2006 | 15594 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 73716 | 0.010 |
Why?
|
United States | 1 | 2017 | 71907 | 0.010 |
Why?
|
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_